dc.contributor
Institut Català de la Salut
dc.contributor
[Gil-Serrano J, Labrador-Horrillo M, Sala-Cunill A, Luengo O, Guilarte M] Servei d’Al·lergologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Malalties Sistèmiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Galvan-Blasco P, Bigas P, Pereira-González J, Cardona V] Servei d’Al·lergologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Malalties Sistèmiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain
dc.contributor
Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author
Bigas, Patricia
dc.contributor.author
Pereira González, Javier
dc.contributor.author
Gil Serrano, Ingrid Johana
dc.contributor.author
Labrador-Horrillo, Moises
dc.contributor.author
GALVÁN BLASCO, PAULA
dc.contributor.author
Sala Cunill, Anna
dc.contributor.author
Luengo Sánchez, Olga
dc.contributor.author
Cardona, Victoria
dc.contributor.author
Guilarte, Mar
dc.date.accessioned
2024-10-31T15:17:02Z
dc.date.available
2024-10-31T15:17:02Z
dc.date.issued
2024-07-08T05:53:16Z
dc.date.issued
2024-07-08T05:53:16Z
dc.date.issued
2024-06-17
dc.identifier
Gil-Serrano J, Labrador-Horrillo M, Galvan-Blasco P, Sala-Cunill A, Bigas P, Pereira-Gonzá lez J, et al. Systemic inflammation biomarkers during angioedema attacks in hereditary angioedema. Front Immunol. 2024 Jun 17;15:1400526.
dc.identifier
https://hdl.handle.net/11351/11675
dc.identifier
10.3389/fimmu.2024.1400526
dc.identifier.uri
https://hdl.handle.net/11351/11675
dc.description.abstract
Acute phase reactants; Hereditary angioedema; Inflammation
dc.description.abstract
Reactants de fase aguda; Angioedema hereditari; Inflamació
dc.description.abstract
Reactantes de fase aguda; Angioedema hereditario; Inflamación
dc.description.abstract
Background: Hereditary angioedema (HAE) is a rare disease characterized by localized and self-limited angioedema (AE) attacks. A local increase of bradykinin (BK) mediates AE attacks in HAE, however the role of inflammation in HAE has been poorly explored We aim to analyze the role of inflammatory mediators in HAE patients during AE attacks.
Methods: Patients with a confirmed HAE diagnosis due to C1 inhibitor deficiency (HAE-C1INH) or patients F12 gene mutations (HAE-FXII) attending to our outpatient clinic between November-2019 and May-2022 were included. Demographic and clinical characteristics were analyzed. Blood samples were collected both during symptom-free periods (baseline) and during HAE attacks, and acute phase reactants (APR), such as serum amyloid A (SAA), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), D-Dimer and white blood cells were measured.
Results: Seventy-eight patients were enrolled in the study, with a predominant representation of women (76%, n=59), and a mean age of 47.8 years (range 6–88). Among them, 67% (n=52) of patients had HAE-C1INH (46 classified as type 1 and 6 as type 2) while 33% (n=26) had HAE-FXII. During attack-free periods, the majority of patients exhibited normal levels of SAA, ESR, D-dimer, ACE and WCC. However, in a subset of patients (16% for SAA, 18% for ESR, and 14.5% for D-dimer), elevations were noted at baseline. Importantly, during HAE attacks, significant increases were observed in SAA in 88% of patients (p< 0.0001 vs. baseline), in ESR in 65% (p= 0.003 vs. baseline) and D-dimer in 71% (p=0.001 vs. baseline) of the patients. A comparison between baseline and acute attack levels in 17 patients revealed significant differences in SAA AA (p<0. 0001), ESR (p<0.0001) and D-dimer (p= 0.004). No significant differences were observed in CRP (p=0.7), ACE (p=0.67) and WCC (p=0.54). These findings remained consistent regardless of HAE type, disease activity or location of angioedema.
Conclusion: The systemic increase in APR observed during HAE attacks suggests that inflammation extends beyond the localized edematous area. This finding underscores the potential involvement of inflammatory pathways in HAE and highlights the need for further investigation into their role in the pathophysiology of HAE.
dc.description.abstract
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. Supported by Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Subdirección General de Investigación Sanitaria, Ministerio de Economía y Competitividad: PI20/01061 (MG).
dc.format
application/pdf
dc.publisher
Frontiers Media
dc.relation
Frontiers in Immunology;15
dc.relation
https://doi.org/10.3389/fimmu.2024.1400526
dc.relation
info:eu-repo/grantAgreement/ES/PE2017-2020/PI20%2F01061
dc.rights
Attribution 4.0 International
dc.rights
http://creativecommons.org/licenses/by/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.subject
Marcadors bioquímics
dc.subject
Malalties congènites
dc.subject
CHEMICALS AND DRUGS::Biological Factors::Biomarkers
dc.subject
DISEASES::Congenital, Hereditary, and Neonatal Diseases and Abnormalities::Genetic Diseases, Inborn::Angioedemas, Hereditary
dc.subject
Other subheadings::Other subheadings::/diagnosis
dc.subject
CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Peptides::Serpins::Complement C1 Inactivator Proteins::Complement C1 Inhibitor Protein
dc.subject
DISEASES::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Inflammation
dc.subject
COMPUESTOS QUÍMICOS Y DROGAS::factores biológicos::biomarcadores
dc.subject
ENFERMEDADES::enfermedades y anomalías neonatales congénitas y hereditarias::enfermedades genéticas congénitas::angioedemas hereditarios
dc.subject
Otros calificadores::Otros calificadores::/diagnóstico
dc.subject
COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::péptidos::serpinas::proteínas inactivadoras del complemento C1::proteína inhibidora del complemento C1
dc.subject
ENFERMEDADES::afecciones patológicas, signos y síntomas::procesos patológicos::inflamación
dc.title
Systemic inflammation biomarkers during angioedema attacks in hereditary angioedema
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion